文献速递外周动脉疾病

下肢血运重建后戒烟趋势与影响因素:VQI分析

Smoking cessation after lower extremity revascularization in the Vascular Quality Initiative.
PubMed 文献 · J Vasc Surg · 2026-03-11

基于VQI外周血管介入、腹股沟下和腹股沟上旁路注册数据,纳入113,757例PVI和33,490例LEB患者,分析下肢血运重建后戒烟趋势及持续吸烟因素,发现活动性吸烟者比例下降但戒烟率亦下降,持续吸烟与年轻、男性、弱势社区、COPD、择期/跛行/腔内手术相关。

要点

  • PVI和LEB术后活动性吸烟比例及戒烟率均显著下降
  • 腹股沟上/下旁路戒烟率高于PVI(38%/39% vs 32%,P<.001)
  • 持续吸烟者更年轻、男性、弱势社区、COPD、择期腔内治疗跛行

核心结论

  • 尽管接受下肢血运重建的吸烟者比例下降,但实现戒烟更具挑战性。
  • 戒烟努力应特别关注年轻、因跛行接受择期腔内下肢血运重建的患者。

研究设计与样本

  • 回顾性队列分析VQI外周血管介入(PVI)、腹股沟下(INFRA)和腹股沟上(SUPRA)旁路注册数据。
  • INFRA和SUPRA模块合并为下肢旁路(LEB),基于长期随访评估戒烟。
  • 纳入113,757例PVI患者和33,490例LEB患者。

主要发现

  • 当前吸烟者在SUPRA旁路中最普遍(56%),其次INFRA旁路(40%)和PVI(35%)。
  • SUPRA和INFRA旁路后戒烟率分别为38%和39%,高于PVI的32%(P<.001)。
  • 2010至2022年,PVI活动性吸烟者比例从37.2%降至33.9%(P=.001),LEB从49.1%降至44.4%(P=.024)。
  • PVI和LEB后戒烟率也显著下降。
  • 长期随访时吸烟者PVI围手术期并发症发生率2.0% vs 3.1%(P<.001),LEB为12% vs 13%(P=.036)。

临床怎么用

  • 应将戒烟干预重点放在年轻、因跛行接受择期腔内下肢血运重建的患者。
  • 关注男性、弱势社区和合并COPD的持续吸烟高风险人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Smoking cessation is crucial for managing peripheral arterial disease and remains a high priority in quality improvement for vascular specialists. The Society for Vascular Surgery launched the CAN-DO campaign in 2023 to promote smoking cessation efforts in the vascular community. This study aimed to examine trends in smoking cessation, identify factors associated with continued smoking after lower extremity revascularization (LER), and investigate the impact of post-LER smoking cessation. METHODS: Patients who were current smokers at the time of index LER in the Vascular Quality Initiative (VQI) peripheral vascular intervention (PVI), infrainguinal (INFRA), and suprainguinal (SUPRA) bypass registries were identified. Patients in the INFRA and SUPRA modules were combined into lower extremity bypass (LEB) and smoking cessation was captured based on long-term follow-up. Trends in smoking status and cessation were investigated. Characteristics and outcomes between patients who continued smoking at follow-up and patients who stopped smoking were compared. Survival analysis was used to analyze long-term outcomes. RESULTS: This analysis included 113,757 patients undergoing PVI and 33,490 patients treated with LEB. Current smokers were most prevalent among patients undergoing SUPRA bypass (56%), followed by INFRA bypass (40%) and PVI (35%). Current smokers were more likely to achieve cessation after SUPRA and INFRA bypass compared with PVI (38% and 39% vs 32% respectively; P < .001). From 2010 to 2022, there was a significant decrease in the percentage of active smokers undergoing PVI (37.2% to 33.9%; P = .001) and LEB (from 49.1% to 44.4%; P = .024). Smoking cessation after both PVI and LEB also exhibited a significant decrease. Patients who continued smoking after LER were more likely to be younger, White males from socioeconomically disadvantaged neighborhoods, with chronic obstructive pulmonary disease undergoing elective PVI for claudication. Patients who were smoking at long-term follow-up after LER were significantly less likely to have experienced any perioperative complication after PVI (2.0% vs 3.1%; P < .001) and LEB (12% vs 13%; P = .036). Regression analysis revealed younger age (odds ratio [OR], 0.99; 95% confidence interval [CI], 0.98-0.99), male sex (OR, 1.08; 95% CI, 1.04-1.13), the most disadvantaged neighborhoods (OR, 1.48; 95% CI, 1.27-1.72), chronic obstructive pulmonary disease (OR, 1.34; 95% CI, 1.28-1.39), elective surgery (OR, 1.25; 95% CI, 1.17-1.35), claudication (OR, 1.17; 95% CI, 1.11-1.22), and an endovascular approach (OR, 1.37; 95% CI, 1.27-1.47) were significantly associated with continued smoking after LER. Survival analysis showed that higher rates of adverse outcomes were noted in patients who were not smoking at the long-term follow-up. CONCLUSIONS: Even though the proportion of smokers undergoing LER is decreasing, achieving smoking cessation has become more challenging. Smoking cessation efforts should particularly focus on younger patients undergoing elective endovascular LER for claudication.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Carter WJ, Schwartz AW, Zwibelman H, et al. Smoking cessation after lower extremity revascularization in the Vascular Quality Initiative. J Vasc Surg. 2026. PMID: 41825793. doi:10.1016/j.jvs.2026.03.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。